FDA finds another impurity in recalled heart drug
date:Sep 18, 2018
sartan for NDEA impurities as well as the NDMA. Testing should wrap up in the next few days.

As we continue to investigate the root cause of the impurities found in products that contain valsartan, our scientists are testing these products to better understand these impurities and to ensure they're not present in other products. We're also taking steps to make sure we're providing stringent oversight of manufacturing processes to reduce the likelihood that impurities could be introduced into ot
5/6 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/18 17:22